These results established the significance of FBXO32 as a driver gene in the progression of LUAD, which suggest that lung adenocarcinoma patients with higher expression of FBXO32 exhibit faster tumor progression, are more likely to develop distant metastasis, and experience poorer prognosis. This evidence concerns the gene FBXO32 and lung adenocarcinoma.